Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001388325-26-000021
Filing Date
2026-05-05
Accepted
2026-05-05 16:15:10
Documents
1
Period of Report
2026-05-01

Document Format Files

Seq Description Document Type Size
1 form4-05052026_040501.html 4  
1 form4-05052026_040501.xml 4 15889
  Complete submission text file 0001388325-26-000021.txt   17708
Mailing Address TUBORG HAVNEVEJ 19 HELLERUP Denmark 2900
Business Address TUBORG HAVNEVEJ 19 HELLERUP Denmark 2900 45 8824 8824
Novo Holdings A/S (Reporting) CIK: 0001388325 (see all company filings)

State of Incorp.: G7 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-43251 | Film No.: 26943359

Mailing Address 105 W FIRST ST. BOSTON MA 02127
Business Address 105 W FIRST ST. BOSTON MA 02127 (206) 707-0340
Avalyn Pharma Inc. (Issuer) CIK: 0001540171 (see all company filings)

EIN.: 452463191 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)